TcrossGlobal

Aspirin-Free Strategy in High Bleeding Risk ACS and Non-ACS Patients Undergoing PCI: A Subgroup Analysis of the STOPDAPT-3 Trial

The STOPDAPT-3 trial demonstrated that among high bleeding risk (HBR) patients, an aspirin-free strategy one month after PCI did not reduce major bleeding regardless of the presence of acute coronary syndrome (ACS), and was associated with an increased risk of myocardial infarction (MI) in ACS patients, Dr. Tetsuya Ishikawa and colleagues, Dokkyo Medical University Saitama Medical Center, Japan, reported in the July issue of Circulation: Cardiovascular Interventions.

The researchers conducted a subgroup analysis of the STOPDAPT-3 trial, stratifying 3,258 HBR patient...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.